LOS ANGELES- A recent study published in the journal Neuroscience indicates that a cannabis extract containing both tetrahydrocannabinol (THC) and cannabidiol (CBD) may significantly reduce neuroinflammation and improve motor function following spinal cord injury.
Conducted by researchers at the University of São Paulo, the study involved administering a cannabis extract to animal models with induced spinal cord compression. Over a 15-day treatment period, subjects receiving the extract exhibited notable reductions in neuroinflammatory markers and demonstrated enhanced locomotor abilities compared to control groups.
These findings align with prior research suggesting the therapeutic potential of cannabinoids in addressing neurological conditions. For instance, a review in Biomedicine & Pharmacotherapy highlights the pharmacological properties of THC and CBD, noting their anti-inflammatory and neuroprotective effects.
While the study offers promising insights, the authors emphasize the necessity for further research to determine optimal dosages, treatment durations, and to assess potential side effects. They also advocate for clinical trials to evaluate the efficacy and safety of cannabis-based therapies in human subjects with spinal cord injuries.
